140 related articles for article (PubMed ID: 7857315)
1. Effects of metalloprotease inhibitors on smooth muscle endothelin-converting enzyme activity.
Balwierczak JL; Kukkola PJ; Savage P; Jeng AY
Biochem Pharmacol; 1995 Jan; 49(3):291-6. PubMed ID: 7857315
[TBL] [Abstract][Full Text] [Related]
2. Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1.
Trapani AJ; Balwierczak JL; Lappe RW; Stanton JL; Graybill SC; Hopkins MF; Savage P; Sperbeck DM; Jeng AY
Biochem Mol Biol Int; 1993 Dec; 31(5):861-7. PubMed ID: 8136704
[TBL] [Abstract][Full Text] [Related]
3. Rhamnose moiety of phosphoramidon is not required for in vivo inhibition of endothelin converting enzyme.
Pollock DM; Shiosaki K; Sullivan GM; Opgenorth TJ
Biochem Biophys Res Commun; 1992 Jul; 186(2):1146-50. PubMed ID: 1497648
[TBL] [Abstract][Full Text] [Related]
4. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi.
Yap EY; Battistini B; McKay KO
Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217
[TBL] [Abstract][Full Text] [Related]
5. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
[TBL] [Abstract][Full Text] [Related]
6. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats.
McMahon EG; Palomo MA; Moore WM
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S29-33. PubMed ID: 1725358
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-converting enzyme and its in vitro and in vivo inhibition.
Yano M; Okada K; Takada J; Hioki Y; Matsuyama K; Fukuroda T; Noguchi K; Nishikibe M; Ikemoto F
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S26-8. PubMed ID: 1725349
[TBL] [Abstract][Full Text] [Related]
8. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane.
Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S
Biochim Biophys Acta; 1993 Feb; 1161(2-3):295-302. PubMed ID: 8431480
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon.
Keller PM; Lee CP; Fenwick AE; Atkinson ST; Elliott JD; DeWolf WE
Biochem Biophys Res Commun; 1996 Jun; 223(2):372-8. PubMed ID: 8670289
[TBL] [Abstract][Full Text] [Related]
10. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.
McMahon EG; Palomo MA; Moore WM; McDonald JF; Stern MK
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):703-7. PubMed ID: 1992461
[TBL] [Abstract][Full Text] [Related]
11. Rat big endothelin-1-induced bronchoconstriction and vasoconstriction in the isolated perfused rat lung: role of endothelin converting enzyme and neutral endopeptidase 24.11.
Held HD; Raschak M; Uhlig S
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):619-24. PubMed ID: 9151301
[TBL] [Abstract][Full Text] [Related]
12. Phosphoramidon-sensitive endothelin converting enzyme in cultured vascular smooth muscle cells converts big endothelin-3 to endothelin-3.
Tsukahara Y; Matsumura Y; Kuninobu K; Kojima T; Takaoka M; Morimoto S
Life Sci; 1993; 53(6):465-71. PubMed ID: 8341132
[TBL] [Abstract][Full Text] [Related]
13. Structure activity relationship of phosphoramidon derivatives for in vivo endothelin-converting-enzyme inhibition.
Bigaud M; Hauss B; Schalk C; Jauch MF; D'Orchymont H
Fundam Clin Pharmacol; 1994; 8(2):155-61. PubMed ID: 8020872
[TBL] [Abstract][Full Text] [Related]
14. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
[TBL] [Abstract][Full Text] [Related]
15. Phosphoramidon, an endothelin converting enzyme inhibitor attenuates local gastric ischemia-reperfusion injury in rats.
Hassan M; Kashimura H; Matsumaru K; Nakahara A; Fukutomi H; Muto H; Goto K; Tanaka N
Life Sci; 1997; 61(10):PL 141-7. PubMed ID: 9296343
[TBL] [Abstract][Full Text] [Related]
16. Characterization of endothelin converting enzyme from intact cells of a permanent human endothelial cell line, EA.hy926.
Ahn K; Pan SM; Zientek MA; Guy PM; Sisneros AM
Biochem Mol Biol Int; 1996 Jun; 39(3):573-80. PubMed ID: 8828809
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of potent heterocyclic thiol-based inhibitors of endothelin-converting enzyme-1.
Firooznia F; Gude C; Chan K; Tan J; Fink CA; Savage P; Beil ME; Bruseo CW; Trapani AJ; Jeng AY
Bioorg Med Chem Lett; 2002 Nov; 12(21):3059-62. PubMed ID: 12372501
[TBL] [Abstract][Full Text] [Related]
18. Evidence for functional endothelin-converting enzyme activity in isolated rat basilar artery: effect of inhibitors.
Vatter H; Schilling L; Schmiedek P; Ehrenreich H
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S64-7. PubMed ID: 9595402
[TBL] [Abstract][Full Text] [Related]
19. Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma.
Lebel N; D'Orléans-Juste P; Fournier A; Sirois P
Br J Pharmacol; 1996 Jan; 117(1):184-8. PubMed ID: 8825361
[TBL] [Abstract][Full Text] [Related]
20. The endothelin-converting enzyme from human umbilical vein is a membrane-bound metalloprotease similar to that from bovine aortic endothelial cells.
Ahn K; Beningo K; Olds G; Hupe D
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8606-10. PubMed ID: 1528868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
